Trending Now
QQQ’s in Holding Pattern Ahead of Big Tech Earnings, NUE Positioned...
The tech-heavy Nasdaq 100 index, represented by the Invesco QQQ Trust (QQQ), experienced a downward trend last week as companies like Netflix...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Cerus Corporation (NASDAQ: CERS) Reports 41% YoY Revenue Growth In Q2...
Cerus Corporation (NASDAQ: CERS) has announced revenue of $37.8 million in Q2 2021, reflecting a 41% YoY increase. This was the highest quarterly total...
MAKE IT MODERN
LATEST REVIEWS
Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Publishes The Findings From Its Investigator Sponsored...
Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) ended September with an announcement through which it revealed the results of its investigator-sponsored study evaluating patients with mild COVID-19.
The...
MAKE IT MODERN
PERFORMANCE TRAINING
Amgen, Inc. (NASDAQ:AMGN) And Its Partners Release GALACTIC-HF Phase 3 Trial Evaluating Omecamtiv Mecarbil
Amgen, Inc. (NASDAQ:AMGN) and its partners Servier and Cytokinetics, Incorporated (NASDAQ:CYTK) recently disclosed the topline results of their Phase 3 trial of a developmental...
HOOKIPA Pharma Inc. (OTCMKTS: HOOK) Announce Restatement and Amendment of Partnership and licensing agreement...
HOOKIPA Pharma Inc. (OTCMKTS: HOOK) has announced the signing of a restated and amended partnership and license deal with Gilead to develop proprietary arenaviral...
Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) Receives Breakthrough Device Designation From FDA for VenoValve
Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) has announced that the US FDA has granted VenoValve Breakthrough Device Designation. VenoValve is Hancock Jaffe's flagship product...
PhaseBio Pharmaceuticals Inc. (NASDAQ:PHAS) Receives FDA Approval For PB1046 In Treatment Of COVID-19
PhaseBio Pharmaceuticals Inc. (NASDAQ:PHAS) stock surged over 80% on Wednesday following the announcement that the FDA had approved the company’s Investigational New Drug application...
180 Life Sciences Corp (NASDAQ: ATNF) and The University of Oxford Have Announced Results...
The University of Oxford and 180 Life Sciences Corp (NASDAQ: ATNF) received their results from the Phase IIb study of adalimumab. The parties had...
MAKE IT MODERN
